A recent study by Structural Heart found that left ventricular assist device patients who later develop moderate to severe aortic regurgitation may benefit from the option to undergo a TAVI (Transcatheter Aortic Valve Implantation).
To learn more, read the article from Structural Heart, The Journal of the Heart Team.
Image via Mayo Clinic
Recommend0 recommendationsPublished in New Talks in Cardiology
Associate Professor Dion Stub, Hope For Hearts and MEDD contributor, shares his views on the challenges for patients with aortic stenosis accessing new treatment technologies.…
Partner 3 Trial shows new clinical data suggesting that TAVI may benefit more patients with Aortic Stenosis Aortic Stenosis is a common heart valve condition…
Considerations for General Practitioners Seeing Heart Failure Patients Heart failure (HF) affects almost half a million adults in Australia, with this number projected to increase…
The Coronavirus (COVID-19) pandemic continues to spread across all countries and is increasingly posing significant health and economic risk to millions of Australians. This infectious…
A new generation of implantable cardiac devices with heart failure diagnostics are enabling Australian cardiologists to better predict the development of heart failure, potentially weeks…
Session expired
Please log in again. The login page will open in a new tab. After logging in you can close it and return to this page.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By using MEDD, you consent to our use of cookies. To find out more about the cookies we use, please see our Privacy Policy
